Cabaletta Bio Inc (CABA) Down 4.02% in Premarket Trading

Cabaletta Bio Inc (CABA) has fallen Wednesday morning, with the stock declining -4.02% in pre-market trading to 13.14. CABA's short-term technical score of 82 indicates that the stock has traded more bullishly over the last month than 82% of stocks on the market. In the Biotechnology industry, which ranks 128 out of 146 industries, CABA ranks higher than 92% of stocks. Cabaletta Bio Inc has risen 6.95% over the past month, closing at $14.75 on November 1. During this period of time, the stock fell as low as $14.75 and as high as $19.22. CABA has an average analyst recommendation of Strong Buy. The company has an average price target of $32.00.

CABA has an Overall Score of 80. Find out what this means to you and get the rest of the rankings on CABA!

See Full CABA Report

Cabaletta Bio Inc has a Long-Term Technical rank of 82. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 18% of the market scoring higher. In the Biotechnology industry which is number 130 by this metric, CABA ranks better than 130% of stocks.

Important Dates for Investors in CABA:

-Cabaletta Bio Inc is set to release earnings on 2024-02-07. Over the last 12 months, the company has reported EPS of $-0.94. -We do not have a set dividend date for Cabaletta Bio Inc at this time. Click Here To Get The Full Report on Cabaletta Bio Inc (CABA)